Patrick Christmas
Chief Legal Officer
Replay available
REGENXBIO Inc. (RGNX) Q2 2026 Earnings Call
REGENXBIO Inc. (NASDAQ: RGNX) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Curran Simpson
President and CEO
Mitch Chan
Chief Financial Officer
Sean McCutcheon
Analyst, Raymond James
Alex Jernahan
Analyst, Bank of America
Lili N. Sango
Analyst, Leerink Partners
Brian Skorney
Analyst, Robert W. Baird & Co.
Yi Chet
Analyst, H.C. Wainwright & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Regenxbio Inc..
Replay transcript excerpt
WEBVTT 00:00:00.071 -- 00:00:05.132 Welcome everyone to the second quarter of 2026 Regenexx BIO 00:00:05.132 -- 00:00:10.134 Earnings Conference Call. My name is Elaine and I will be your conference operator 00:00:10.134 -- 00:00:14.935 today. All lines have been placed on mute to prevent any background noise. 00:00:14.935 -- 00:00:19.416 And after the speaker's remarks, there will be a question and answer session. 00:00:19.416 -- 00:00:25.118 If you would like to ask a question during this time, simply press star then one, 00:00:25.118 -- 00:00:31.214 number one on your telephone keyboard. To withdraw your question, press star 1 again. 00:00:31.214 -- 00:00:36.295 At this time, I'd like to turn the conference over to Patrick Christmas, Chief 00:00:36.295 -- 00:00:41.536 Legal Officer of Regenexx BIO. Please go ahead. 00:00:41.536 -- 00:00:44.517 Good morning, and thank you for joining us today. 00:00:44.517 -- 00:00:48.517 Earlier this morning, Regenexx BIO released financial and operating results for the second 00:00:48.517 -- 00:00:51.578 quarter ended June 30, 2026. 00:00:51.580 -- 00:00:57.181 The press release is available on our website at www.genxbio.com. 00:00:58.382 -- 00:01:01.983 Today's conference call will include forward-looking statements regarding our financial 00:01:01.983 -- 00:01:05.603 outlook in addition to regulatory and product development plans. 00:01:05.603 -- 00:01:09.424 These forward-looking statements are subject to risks and uncertainties that may cause 00:01:09.424 -- 00:01:14.406 actual results to differ from those forecasted and can be identified by words such as 00:01:14.406 -- 00:01:19.607 expect, plan, will, may, anticipate, believe, should, intend, and other words 00:01:19.607 -- 00:01:23.269 of similar meaning. Any such forward-...